CAS 108212-75-5
:Caliquamicina γ1I
Descrição:
Caliquamicina γ1I é um potente antibiótico antitumoral derivado da bactéria Micromonospora echinospora. Pertence à classe de compostos enediyne, que são conhecidos por sua capacidade de induzir quebras nas cadeias de DNA, levando a efeitos citotóxicos em células que se dividem rapidamente. Este composto exibe uma estrutura complexa caracterizada por um núcleo bicíclico único que contém uma porção enediyne altamente reativa, que é crucial para seu mecanismo de ação. Caliquamicina γ1I é particularmente notável por sua seletividade em relação às células cancerosas, tornando-se um assunto de interesse em terapias direcionadas ao câncer. Sua alta potência é acompanhada por uma toxicidade significativa, exigindo manuseio e administração cuidadosos em ambientes clínicos. O composto tem sido estudado por seu potencial uso em conjugados de anticorpos e medicamentos, onde pode ser ligado a anticorpos que visam especificamente as células tumorais, aumentando assim a eficácia terapêutica enquanto minimiza danos aos tecidos normais. No geral, Caliquamicina γ1I representa um avanço significativo no desenvolvimento de agentes quimioterápicos, particularmente no contexto de estratégias de tratamento direcionadas ao câncer.
Fórmula:C55H74IN3O21S4
InChI:InChI=1S/C55H74IN3O21S4/c1-12-57-30-24-73-35(22-34(30)68-6)78-48-43(63)40(26(3)75-53(48)77-33-17-15-13-14-16-19-55(67)23-32(61)41(58-54(66)72-10)38(33)29(55)18-20-82-84-81-11)59-80-36-21-31(60)50(28(5)74-36)83-51(65)37-25(2)39(56)46(49(71-9)45(37)69-7)79-52-44(64)47(70-8)42(62)27(4)76-52/h13-14,18,26-28,30-31,33-36,40,42-44,47-48,50,52-53,57,59-60,62-64,67H,12,20-24H2,1-11H3,(H,58,66)/b14-13-,29-18+/t26-,27+,28-,30+,31+,33+,34+,35+,36+,40-,42+,43+,44-,47-,48-,50-,52+,53+,55+/m1/s1
Chave InChI:InChIKey=HXCHCVDVKSCDHU-PJKCJEBCSA-N
SMILES:C(\CSSSC)=C/1\C=2[C@@H](O[C@H]3[C@H](O[C@H]4C[C@H](OC)[C@@H](NCC)CO4)[C@@H](O)[C@H](NO[C@H]5C[C@H](O)[C@H](SC(=O)C6=C(OC)C(OC)=C(O[C@H]7[C@H](O)[C@H](OC)[C@@H](O)[C@H](C)O7)C(I)=C6C)[C@@H](C)O5)[C@@H](C)O3)C#C/C=C\C#C[C@]1(O)CC(=O)C2NC(OC)=O
Sinónimos:- Benzenecarbothioic acid, 4-((6-deoxy-3-O-methyl-alpha-L-mannopyranosyl)oxy)-3-iodo-5,6-dimethoxy-2-methyl-, 4''-ester with methyl (8-((4,6-dideoxy-2-O-(2,4-dideoxy-4-(ethylamino)-3-O-methyl-alpha-L-threo-pentapyranosyl)-4-(((2,6-dideoxy-4-thio-beta-D-ribo-hexopyranosyl)oxy)amino)-beta-D-glucopyranosyl)oxy)-1-hydroxy-13-(2-(methyltrithio)ethylidene)-11-oxobicyclo(7.3.1)trideca-4,9-diene-2,6-diyn-10-yl)carbamate, (1R-(1R*,4Z,8S*,13E))-
- Benzenecarbothioic acid, 4-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methyl-, 4′′-ester with methyl [8-[[4,6-dideoxy-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-<smallcap>L</smallcap>-threo-pentopyranosyl]-4-[[(2,6-dideoxy-4-thio-β-<smallcap>D</smallcap>-ribo-hexopyranosyl)oxy]amino]-β-<smallcap>D</span>-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]carbamate, [1R-(1R*,4Z,8S*,13E)]-
- Calicheamicin
- Calicheamicin γ<sub>1</sub>
- Calicheamicin γ<sub>1</sub><sup>I</sup>
- Calicheamicin γ<sub>1α</sub><sup>I</sup>
- Calichemicin gamma1
- Calichemicin γ<sub>1</sub>
- Carbamic acid, ((1R,4Z,8S,13E)-8-((4,6-dideoxy-4-(((2,6-dideoxy-4-S-(4-((6-deoxy-3-O-methyl-alpha-L-mannopyranopyranosyl)oxy)-3-iodo-5,6-dimethoxy-2-methylbenzoyl)-4-thio-beta-D-ribo-hexopyranosyl)oxy)amino)-2-O-(2,4-dideoxy-4-(ethylamino)-3-O-methyl-alpha-L-threo-pentopyranosyl)-beta-D-glucopyranosyl)oxy)-1-hydroxy-13-(2-(methyltrithio)ethylidene)-11-oxobicyclo(7.3.1)trideca-4,9-diene-2,6-diyn-10-yl)-, methyl ester
- Carbamic acid, N-[(1R,4Z,8S,13E)-8-[[4,6-dideoxy-4-[[[2,6-dideoxy-4-S-[4-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl]-4-thio-β-<smallcap>D</smallcap>-ribo-hexopyranosyl]oxy]amino]-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-<smallcap>L</smallcap>-threo-pentopyranosyl]-β-<smallcap>D</span>-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]-, methyl ester
- Carbamic acid, [(1R,4Z,8S,13E)-8-[[4,6-dideoxy-4-[[[2,6-dideoxy-4-S-[4-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl]-4-thio-β-<smallcap>D</smallcap>-ribo-hexopyranosyl]oxy]amino]-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-<smallcap>L</smallcap>-threo-pentopyranosyl]-β-<smallcap>D</span>-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]-, methyl ester
- Carbamic acid, [8-[[4,6-dideoxy-4-[[[2,6-dideoxy-4-S-[4-[(6-deoxy-3-O-methyl-α-<span class="text-smallcaps">L</smallcap>-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl]-4-thio-β-<smallcap>D</smallcap>-ribo-hexopyranosyl]oxy]amino]-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-<smallcap>L</smallcap>-threo-pentopyranosyl]-β-<smallcap>D</span>-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]-, methyl ester, [1R-(1R*,4Z,8S*,13E)]-
- LL-E 33288γ1-I
- S-(6-{[(5-{[5-(ethylamino)-4-methoxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-{[(2S,5Z,9R,13E)-9-hydroxy-12-[(methoxycarbonyl)amino]-13-[2-(methyltrisulfanyl)ethylidene]-11-oxobicyclo[7.3.1]trideca-1(12),5-diene-3,7-diyn-2-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl)amino]oxy}-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl) 4-[(3,5-dihydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzenecarbothioate (non-preferred name)
- S-[(2R,3S,4S,6S)-6-({[(2R,3S,4S,5R)-5-{[(2S,4S,5S)-5-(ethylamino)-4-methoxytetrahydro-2H-pyran-2-yl]oxy}-4-hydroxy-6-{[(2S,5Z,9S,13E)-9-hydroxy-12-[(methoxycarbonyl)amino]-13-[2-(methyltrisulfanyl)ethylidene]-11-oxobicyclo[7.3.1]trideca-1(12),5-diene-3,7-diyn-2-yl]oxy}-2-methyltetrahydro-2H-pyran-3-yl]amino}oxy)-4-hydroxy-2-methyltetrahydro-2H-pyran-3-yl] 4-{[(2S,3R,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-3-iodo-5,6-dimethoxy-2-methylbenzenecarbothioate (non-preferred name)
- Benzenecarbothioic acid, 4-[(6-deoxy-3-O-methyl-α-L-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methyl-, 4′′-ester with methyl [8-[[4,6-dideoxy-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-L-threo-pentopyranosyl]-4-[[(2,6-dideoxy-4-thio-β-D-ribo-hexopyranosyl)oxy]amino]-β-D-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]carbamate, [1R-(1R*,4Z,8S*,13E)]-
- Calicheamicin γ1αI
- Carbamic acid, N-[(1R,4Z,8S,13E)-8-[[4,6-dideoxy-4-[[[2,6-dideoxy-4-S-[4-[(6-deoxy-3-O-methyl-α-L-mannopyranosyl)oxy]-3-iodo-5,6-dimethoxy-2-methylbenzoyl]-4-thio-β-D-ribo-hexopyranosyl]oxy]amino]-2-O-[2,4-dideoxy-4-(ethylamino)-3-O-methyl-α-L-threo-pentopyranosyl]-β-D-glucopyranosyl]oxy]-1-hydroxy-13-[2-(methyltrithio)ethylidene]-11-oxobicyclo[7.3.1]trideca-4,9-diene-2,6-diyn-10-yl]-, methyl ester
- Calichemicin γ1
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produtos.
Calicheamicin gamma1
CAS:<p>Calicheamicin γ1 is a highly potent cytotoxic agent used as a payload in antibody–drug conjugates (ADCs). It binds to the minor groove of DNA and induces double-strand breaks through a radical-mediated mechanism, leading to cell death even at extremely low concentrations. Its remarkable potency makes it effective for targeted cancer therapies when precisely delivered to tumor cells via an antibody.</p>Fórmula:C55H74IN3O21S4Pureza:Min. 98 Area-%Cor e Forma:PowderPeso molecular:1,368.35 g/molCalicheamicin
CAS:Calicheamicin (Calicheamicin γ1) is an antitumor antibiotic and is a DNA synthesis inhibitor. It also is a cytotoxic agent that causes double-strand DNA breaks.Fórmula:C55H74IN3O21S4Pureza:98.22% - 98.78%Cor e Forma:SolidPeso molecular:1368.35



